Pfizer CEO: Wyeth Acquisition Will Avoid Mistakes of Past

Eager to dispel doubts about the difficulties of executing Pfizer Inc.'s $68 billion tie-up with Wyeth, Pfizer's CEO said it will be done more like microsurgery than just stitching two huge corporations together.